𝔖 Bobbio Scriptorium

✦ LIBER ✦

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age–a sibling control study

✍ Scribed by JJ McGill; AC Inwood; DJ Coman; ML Lipke; D De Lore; SJ Swiedler; JJ Hopwood

Book ID: 110888938
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 600 KB
Volume: 77
Category: Article
ISSN: 0009-9163
DOI: 10.1111/j.1399-0004.2009.01324.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enzyme replacement therapy for mucopolys

Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up

✍ A Tylki- Szymanska; A Jurecka; Z Zuber; A Rozdzynska; J Marucha; B Czartoryska 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Enzyme replacement therapy for mucopolys

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)

✍ James E Wraith; Lorne A Clarke; Michael Beck; Edwin H Kolodny; Gregory M Pastore 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Efficacy and safety of enzyme replacemen

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

✍ Hendriksz, Christian J.; Burton, Barbara; Fleming, Thomas R.; Harmatz, Paul; Hug 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 358 KB

Enzyme replacement therapy for mucopolys

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study

✍ Paul Harmatz; Roberto Giugliani; Ida Schwartz; Nathalie Guffon; Elisa Leão Teles 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Enzyme replacement therapy for mucopolys

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study

✍ Paul Harmatz; Roberto Giugliani; Ida Schwartz; Nathalie Guffon; Elisa Leão Teles 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB